Tokyo, Japan

Kunio Higashi


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1990-1992

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kunio Higashi: Innovator in Antibacterial Agents

Introduction

Kunio Higashi is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of antibacterial agents, holding 2 patents that showcase his innovative work. His research focuses on developing new derivatives of penem, which are crucial in combating antibiotic-resistant bacteria.

Latest Patents

Higashi's latest patents include groundbreaking compounds that serve as antibacterial agents. These compounds exhibit an extremely wide antibacterial spectrum and demonstrate high sensitivity to bacteria that are resistant to conventional penicillins and cephalosporin antibiotics. They are also recognized for their excellent physico-chemical stability, solubility in water, and biological stability, particularly against decomposition by enzymes such as dehydropeptidase I in the kidney and β-lactamase. The derivatives of penem can be synthesized by reacting a 2-substituted sulfinyl derivative of penem with a thiol compound, followed by the optional removal of protective groups and further alkylation of the reaction product.

Career Highlights

Throughout his career, Kunio Higashi has worked with prominent companies in the pharmaceutical industry, including Daiichi Seiyaku Co., Ltd. and Daiichi Pharmaceutical Co., Ltd. His work has significantly impacted the development of new antibacterial agents, contributing to advancements in medical treatments.

Collaborations

Higashi has collaborated with esteemed colleagues such as Makoto Sato and Makoto Takemura. These partnerships have fostered innovation and have been instrumental in the research and development of his patented compounds.

Conclusion

Kunio Higashi's contributions to the field of antibacterial agents through his innovative patents highlight his role as a key inventor in the pharmaceutical industry. His work continues to pave the way for new treatments against antibiotic-resistant bacteria.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…